Fig. 2

Illustrative diagram of the proposed method. a Data collection from drug and protein-related databases; b Construction of drug-drug similarity network, protein-protein similarity network and drug-protein association network; c Random walk with restart on drug-protein heterogenous network; d Feature representations of drug combinations via feature extraction process; e Training gradient tree boosting classifier